Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cai Grau, Morten Høyer, Markus Alber, Jens Overgaard, Jacob Christian Lindegaard & Ludvig Paul Muren. (2013) Biology-guided adaptive radiotherapy (BiGART) – more than a vision?. Acta Oncologica 52:7, pages 1243-1247.
Read now
Read now
Cai Grau, Dag Rune Olsen, Jens Overgaard, Morten Høyer, Jacob Christian Lindegaard & Ludvig Paul Muren. (2010) Biology-guided adaptive radiation therapy – presence or future?. Acta Oncologica 49:7, pages 884-887.
Read now
Read now
Articles from other publishers (27)
Hala Fawzy Mohamed Kamel & Hiba Saeed A. Bagader Al-Amodi. (2017) Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine. Genomics, Proteomics & Bioinformatics 15:4, pages 220-235.
Crossref
Crossref
Philip P. Connell & Ralph R. Weichselbaum. 2016. Holland‐Frei Cancer Medicine. Holland‐Frei Cancer Medicine
1
9
.
Michael Fraser, Theo van der Kwast, Paul C. Boutros & Robert G. Bristow. 2017. Management of Prostate Cancer. Management of Prostate Cancer
97
110
.
Nicolas Foray, Michel Bourguignon & Nobuyuki Hamada. (2016) Individual response to ionizing radiation. Mutation Research/Reviews in Mutation Research 770, pages 369-386.
Crossref
Crossref
Anna Wilkins, David Dearnaley & Navita Somaiah. (2015) Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer. BioMed Research International 2015, pages 1-9.
Crossref
Crossref
Arabella Young, Rachael Berry, Adele F Holloway, Nicholas B Blackburn, Joanne L Dickinson, Marketa Skala, Jessica L Phillips & Kate H Brettingham-Moore. (2014) RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization. BMC Cancer 14:1.
Crossref
Crossref
Michael J. Donovan & Carlos Cordon-Cardo. (2014) Genomic analysis in active surveillance. Current Opinion in Urology 24:3, pages 303-310.
Crossref
Crossref
Michael Fraser, Alejandro Berlin, Veronique Ouellet, Fred Saad & Robert G. Bristow. 2014. Cancer Genomics. Cancer Genomics
233
245
.
F M Frame, D Pellacani, A T Collins, M S Simms, V M Mann, GDD Jones, M Meuth, R G Bristow & N J Maitland. (2013) HDAC inhibitor confers radiosensitivity to prostate stem-like cells. British Journal of Cancer 109:12, pages 3023-3033.
Crossref
Crossref
Alan Dal Pra, Emilie Lalonde, Jenna Sykes, Fiona Warde, Adrian Ishkanian, Alice Meng, Chad Maloff, John Srigley, Anthony M. Joshua, Gyorgy Petrovics, Theodorus van der Kwast, Andrew Evans, Michael Milosevic, Fred Saad, Colin Collins, Jeremy Squire, Wan Lam, Tarek A. Bismar, Paul C. Boutros & Robert G. Bristow. (2013)
TMPRSS2-ERG
Status Is Not Prognostic Following Prostate Cancer Radiotherapy: Implications for Fusion Status and DSB Repair
. Clinical Cancer Research 19:18, pages 5202-5209.
Crossref
Crossref
S. Sridharan, A. Dal Pra, C. Catton, R.G. Bristow & P. Warde. (2013) Locally Advanced Prostate Cancer: Current Controversies and Optimisation Opportunities. Clinical Oncology 25:8, pages 499-505.
Crossref
Crossref
Dominique TrudelGaetano ZafaranaJenna SykesCherry L. HaveRobert G. BristowTheo van der Kwast. (2013)
4FISH-IF, a Four-Color Dual-Gene FISH Combined with p63 Immunofluorescence to Evaluate
NKX3.1
and
MYC
Status in Prostate Cancer
. Journal of Histochemistry & Cytochemistry 61:7, pages 500-509.
Crossref
Crossref
Michael J. Donovan & Carlos Cordon-Cardo. (2013) Predicting high-risk disease using tissue biomarkers. Current Opinion in Urology 23:3, pages 245-251.
Crossref
Crossref
Danny Vesprini, Stanley Liu & Robert Nam. (2013) Predicting high risk disease using serum and DNA biomarkers. Current Opinion in Urology 23:3, pages 252-260.
Crossref
Crossref
Stanley L. LiauwPhilip P. ConnellRalph R. Weichselbaum. (2013) New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology. Science Translational Medicine 5:173.
Crossref
Crossref
Sandra Klein, Fiona M. Frame & Norman J. Maitland. 2013. Stem Cells: Current Challenges and New Directions. Stem Cells: Current Challenges and New Directions
279
300
.
Fiona M. Frame & Norman J. Maitland. 2013. Stem Cells and Prostate Cancer. Stem Cells and Prostate Cancer
51
75
.
Chad M. McKee, Danmei Xu, Yunhong Cao, Sheheryar Kabraji, Danny Allen, Veerle Kersemans, John Beech, Sean Smart, Freddie Hamdy, Adrian Ishkanian, Jenna Sykes, Melania Pintile, Michael Milosevic, Theodorus van der Kwast, Gaetano Zafarana, Varune Rohan Ramnarine, Igor Jurisica, Chad Mallof, Wan Lam, Robert G. Bristow & Ruth J. Muschel. (2012) Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma. Journal of Clinical Investigation 122:11, pages 4025-4036.
Crossref
Crossref
Gaetano Zafarana, Adrian S. Ishkanian, Chad A. Malloff, Jennifer A. Locke, Jenna Sykes, John Thoms, Wan L. Lam, Jeremy A. Squire, Maisa Yoshimoto, Varune Rohan Ramnarine, Alice Meng, Omar Ahmed, Igor Jurisca, Michael Milosevic, Melania Pintilie, Theo van der Kwast & Robert G. Bristow. (2012)
Copy number alterations of
c‐MYC
and
PTEN
are prognostic factors for relapse after prostate cancer radiotherapy
. Cancer 118:16, pages 4053-4062.
Crossref
Crossref
Danny Vesprini, Charles Catton, Lindsay Jacks, Gina Lockwood, Tara Rosewall, Andrew Bayley, Peter Chung, Mary Gospodarowicz, Cynthia Ménard, Michael Milosevic, Alan Nichol, Marketa Skala, Padraig Warde & Robert G. Bristow. (2012) Inverse Relationship Between Biochemical Outcome and Acute Toxicity After Image-Guided Radiotherapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics 83:2, pages 608-616.
Crossref
Crossref
Maisa Yoshimoto, Olga Ludkovski, Dave DeGrace, Julia L. Williams, Andrew Evans, Kanishka Sircar, Tarek A. Bismar, Paulo Nuin & Jeremy A. Squire. (2012) PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications. Genes, Chromosomes and Cancer 51:2, pages 149-160.
Crossref
Crossref
Jennifer A. Locke, Gaetano Zafarana, Adrian S. Ishkanian, Michael Milosevic, John Thoms, Cherry L. Have, Chad A. Malloff, Wan L. Lam, Jeremy A. Squire, Melania Pintilie, Jenna Sykes, Varune Rohan Ramnarine, Alice Meng, Omer Ahmed, Igor Jurisica, Theo van der Kwast & Robert G. Bristow. (2012)
NKX3.1
Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy
. Clinical Cancer Research 18:1, pages 308-316.
Crossref
Crossref
Danny Vesprini & Robert Nam. 2012. Active Surveillance for Localized Prostate Cancer. Active Surveillance for Localized Prostate Cancer
35
54
.
Michael J. Donovan & Carlos Cordon-Cardo. 2012. Active Surveillance for Localized Prostate Cancer. Active Surveillance for Localized Prostate Cancer
23
34
.
Todd A. Swanson, Sarah A. Krueger, Sandra Galoforo, Bryan J. Thibodeau, Alvaro A. Martinez, George D. Wilson & Brian Marples. (2011) TMPRSS2/ERG fusion gene expression alters chemo‐ and radio‐responsiveness in cell culture models of androgen independent prostate cancer. The Prostate 71:14, pages 1548-1558.
Crossref
Crossref
Peter M. Glazer, Jennifer Grandis, Simon N. Powell, J. Martin Brown, Thomas Helleday, Robert Bristow, Garth Powis, Richard P. Hill, Quynh-Thu Le, Richard Pelroy, Suresh Mohla & Eric J. Bernhard. (2011) Radiation Resistance in Cancer Therapy: Meeting Summary and Research Opportunities Report of an NCI Workshop held September 1–3, 2010. Radiation Research 176:3, pages e0016-e0021.
Crossref
Crossref
Adeline Granzotto, Aurélie Joubert, Muriel Viau, Clément Devic, Mira Maalouf, Charles Thomas, Guillaume Vogin, Karim Malek, Catherine Colin, Jacques Balosso & Nicolas Foray. (2011) Réponse individuelle aux radiations ionisantes : quel(s) test(s) prédictif(s) choisir ?. Comptes Rendus Biologies 334:2, pages 140-157.
Crossref
Crossref